Literature DB >> 25267107

Management of pelvic floor disorders: biofeedback and more.

David Prichard1, Adil E Bharucha.   

Abstract

OPINION STATEMENT: Defecatory disorders (DD) and fecal incontinence (FI) are common conditions. DD are primarily attributable to impaired rectoanal function during defecation or structural defects. FI is caused by one or more disturbances of anorectal continence mechanisms. Altered stool consistency may be the primary cause or may unmask anorectal deficits in both conditions. Diagnosis and management requires a systematic approach beginning with a thorough clinical assessment. Symptoms do not reliably differentiate a DD from other causes of constipation such as slow or normal transit constipation. Therefore, all constipated patients who do not adequately respond to medical therapy should be considered for anorectal testing to identify a DD. Preferably, two tests indicating impaired defecation are required to diagnose a DD. Patients with DD, or those for whom testing is not available and the clinical suspicion is high, should be referred for biofeedback-based pelvic floor physical therapy. Patients with FI should be managed with lifestyle modifications, pharmacotherapy for bowel disturbances, and management of local anorectal problems (e.g., hemorrhoids). When these measures are not beneficial, anorectal testing and pelvic floor retraining with biofeedback therapy should be considered. Sacral nerve stimulation or perianal bulking could be considered in patients who have persistent symptoms despite optimal management of bowel disturbances and pelvic floor retraining.

Entities:  

Year:  2014        PMID: 25267107      PMCID: PMC4206602          DOI: 10.1007/s11938-014-0033-8

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  62 in total

Review 1.  Outcome measures for fecal incontinence: anorectal structure and function.

Authors:  Adil E Bharucha
Journal:  Gastroenterology       Date:  2004-01       Impact factor: 22.682

2.  Botulinum toxin in the treatment of outlet obstruction constipation caused by puborectalis syndrome.

Authors:  G Maria; G Brisinda; A R Bentivoglio; E Cassetta; A Albanese
Journal:  Dis Colon Rectum       Date:  2000-03       Impact factor: 4.585

3.  Botulinum toxin type-A in therapy of patients with anismus.

Authors:  Y Ron; Y Avni; A Lukovetski; J Wardi; D Geva; S Birkenfeld; Z Halpern
Journal:  Dis Colon Rectum       Date:  2001-12       Impact factor: 4.585

4.  Manometric tests of anorectal function in healthy adults.

Authors:  S S Rao; R Hatfield; E Soffer; S Rao; J Beaty; J L Conklin
Journal:  Am J Gastroenterol       Date:  1999-03       Impact factor: 10.864

5.  Supplementation with dietary fiber improves fecal incontinence.

Authors:  D Z Bliss; H J Jung; K Savik; A Lowry; M LeMoine; L Jensen; C Werner; K Schaffer
Journal:  Nurs Res       Date:  2001 Jul-Aug       Impact factor: 2.381

6.  Randomized, controlled trial of biofeedback with anal manometry, transanal ultrasound, or pelvic floor retraining with digital guidance alone in the treatment of mild to moderate fecal incontinence.

Authors:  Michael J Solomon; Chet K Pager; Jenny Rex; Rachael Roberts; Jane Manning
Journal:  Dis Colon Rectum       Date:  2003-06       Impact factor: 4.585

7.  Randomized controlled trial of topical phenylephrine in the treatment of faecal incontinence.

Authors:  E A Carapeti; M A Kamm; R K Phillips
Journal:  Br J Surg       Date:  2000-01       Impact factor: 6.939

8.  Topical phenylephrine increases anal canal resting pressure in patients with faecal incontinence.

Authors:  M J Cheetham; M A Kamm; R K Phillips
Journal:  Gut       Date:  2001-03       Impact factor: 23.059

9.  Randomized controlled trial of biofeedback for fecal incontinence.

Authors:  Christine Norton; Sonya Chelvanayagam; Jenifer Wilson-Barnett; Sally Redfern; Michael A Kamm
Journal:  Gastroenterology       Date:  2003-11       Impact factor: 22.682

10.  Bleeding, incontinence, pain and constipation after STARR transanal double stapling rectotomy for obstructed defecation.

Authors:  G Dodi; R Pietroletti; G Milito; G Binda; M Pescatori
Journal:  Tech Coloproctol       Date:  2003-10       Impact factor: 3.781

View more
  1 in total

Review 1.  Biofeedback for Pelvic Floor Disorders.

Authors:  Melissa Hite; Thomas Curran
Journal:  Clin Colon Rectal Surg       Date:  2020-09-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.